<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26084044</article-id><article-id pub-id-type="pmc">4490514</article-id><article-id pub-id-type="doi">10.3390/ijms160613649</article-id><article-id pub-id-type="publisher-id">ijms-16-13649</article-id><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>Alleged Detrimental Mutations in the <italic>SMPD1</italic> Gene in Patients with Niemann-Pick Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rhein</surname><given-names>Cosima</given-names></name></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;hle</surname><given-names>Christiane</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kornhuber</surname><given-names>Johannes</given-names></name></contrib><contrib contrib-type="author"><name><surname>Reichel</surname><given-names>Martin</given-names></name><xref rid="c1-ijms-16-13649" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Alexov</surname><given-names>Emil</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-16-13649">Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany; E-Mails: <email>cosima.rhein@uk-erlangen.de</email> (C.R.); <email>christiane.muehle@uk-erlangen.de</email> (C.M.); <email>johannes.kornhuber@uk-erlangen.de</email> (J.K.)</aff><author-notes><corresp id="c1-ijms-16-13649"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>martin.reichel@uk-erlangen.de</email>; Tel.: +49-9131-85-46329; Fax: +49-9131-85-36381.</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>16</volume><issue>6</issue><fpage>13649</fpage><lpage>13652</lpage><history><date date-type="received"><day>05</day><month>5</month><year>2015</year></date><date date-type="accepted"><day>08</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2015</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Loss-of-function mutations in the sphingomyelin phosphodiesterase 1 (<italic>SMPD1</italic>) gene are associated with decreased catalytic activity of acid sphingomyelinase (ASM) and are the cause of the autosomal recessive lysosomal storage disorder Niemann-Pick disease (NPD) types A and B. Currently, &#x0003e;100 missense mutations in <italic>SMPD1</italic> are listed in the Human Gene Mutation Database. However, not every sequence variation in <italic>SMPD1</italic> is detrimental and gives rise to NPD. We have analysed several alleged <italic>SMPD1</italic> missense mutations mentioned in a recent publication and found them to be common variants of <italic>SMPD1</italic> that give rise to normal <italic>in vivo</italic> and <italic>in vitro</italic> ASM activity. (Comment on Manshadi <italic>et al</italic>. <italic>Int. J. Mol. Sci.</italic>
<bold>2015</bold>, <italic>16</italic>, 6668&#x02013;6676).</p></abstract><kwd-group><kwd>gene variant</kwd><kwd>missense mutation</kwd><kwd>Niemann-Pick disease</kwd><kwd>polymorphism</kwd><kwd>sphingomyelin phosphodiesterase</kwd></kwd-group></article-meta></front><body><sec><title>1. To the Editor</title><p>Loss-of-function mutations in the sphingomyelin phosphodiesterase 1 (<italic>SMPD1</italic>) gene are associated with decreased catalytic activity of acid sphingomyelinase (ASM) and are the cause of the autosomal recessive lysosomal storage disorder Niemann-Pick disease types A and B (NPD). Currently, &#x0003e;100 missense mutations in <italic>SMPD1</italic> are listed in the Human Gene Mutation Database. However, not every sequence variation in <italic>SMPD1</italic> is detrimental and gives rise to NPD.</p><p>In order to identify mutations in the <italic>SMPD1</italic> gene that potentially explain increased ASM activity associated with major depressive disorder [<xref rid="B1-ijms-16-13649" ref-type="bibr">1</xref>] we performed a re-sequencing analysis of the six exons of <italic>SMPD1</italic>. This region includes a 1896 bp open reading frame that encodes a 631 amino acid protein according to NCBI Reference Sequence NM_000543.4. We identified three non-synonymous single nucleotide polymorphisms (SNP)-c.973C&#x0003e;G (p.P325A), c.1460C&#x0003e;T (p.A487V) and c.1522G&#x0003e;A (p.G508R; rs1050239)-as well as a bipartite polymorphic site including the non-synonymous SNP c.107T&#x0003e;C (p.V36A; rs1050228), which is located adjacent to a polymorphic region composed of a variable number of hexanucleotide sequences. Two of these variants, p.P325A and p.A487V, were previously reported to constitute loss-of-function mutations of <italic>SMPD1</italic> [<xref rid="B2-ijms-16-13649" ref-type="bibr">2</xref>], whereas the other two, p.G508R and the hexanucleotide repeat, an association with NPD was ruled out [<xref rid="B3-ijms-16-13649" ref-type="bibr">3</xref>,<xref rid="B4-ijms-16-13649" ref-type="bibr">4</xref>]. To analyze the functional implications of these polymorphisms in detail, we first conducted genotype-phenotype correlations in different human samples (e.g., a comparison of individual <italic>SMPD1</italic> genotypes with the respective <italic>in vivo</italic> ASM activities) and, second, cloned the respective cDNAs for transient transfection studies. Hereby, we were able to demonstrate that the carriers of c.1460C&#x0003e;T (minor allele frequency ~1%) displayed secreted (S-) and lysosomal (L-) ASM activities in the normal range [<xref rid="B5-ijms-16-13649" ref-type="bibr">5</xref>]. Moreover, transient transfection of c.1460T-cDNA into HeLa and MDCK cells resulted in S- and L-ASM activities similar to wild-type ASM [<xref rid="B5-ijms-16-13649" ref-type="bibr">5</xref>]. The genotype-phenotype comparison for c.1522G&#x0003e;A (minor allele frequency ~27%), on the other hand, revealed a significant association especially with the S-ASM activity, which decreased with the number of A alleles in a gene-dosage dependent manner [<xref rid="B6-ijms-16-13649" ref-type="bibr">6</xref>]. S-ASM activity in subjects homozygous for c.1522G&#x0003e;A was 50% decreased compared to subjects homozygous for the major allele c.1522G [<xref rid="B6-ijms-16-13649" ref-type="bibr">6</xref>]. In sharp contrast, NPD patients and carriers of NPD alleles were reported to display S-ASM activities &#x0003c;3% and about 20% of normal values, respectively [<xref rid="B7-ijms-16-13649" ref-type="bibr">7</xref>]. Thus, the only moderately decreased S-ASM activity in subjects homozygous for c.1522A and the high allele frequency argue strongly against the notion that c.1522G&#x0003e;A constitutes a loss-of-function mutation causing NPD. In addition, a transient transfection of a c.1522A-construct into HeLa and MCDK cells resulted in L- and S-ASM activities comparable to wild-type ASM (<xref ref-type="fig" rid="ijms-16-13649-f001">Figure 1</xref>). The functional relevance of c.107T&#x0003e;C was analyzed together with that of the adjacent polymorphic hexanucleotide repeat. While we obtained data showing that less repeats of the hexanucleotide motif are associated with slightly decreased S-ASM activity <italic>in vivo</italic> and <italic>in vitro</italic> [<xref rid="B8-ijms-16-13649" ref-type="bibr">8</xref>], we did not observe a significant reduction of ASM activity associated with c.107T&#x0003e;C, neither <italic>in vivo</italic> nor <italic>in vitro</italic> (<xref ref-type="fig" rid="ijms-16-13649-f001">Figure 1</xref>). In contrast, transient transfection of a c.973G-construct into HeLa and MDCK cells did not increase ASM activity compared to control cells, thus confirming that c.973C&#x0003e;G is a NPD mutation (<xref ref-type="fig" rid="ijms-16-13649-f001">Figure 1</xref>).</p><fig id="ijms-16-13649-f001" position="float"><label>Figure 1</label><caption><p>Analysis of sphingomyelin phosphodiesterase 1 (<italic>SMPD1</italic>) sequence variations by transient transfection studies. The full-length <italic>SMPD1</italic> cDNA was cloned into the FLAG-N2 expression vector, and the <italic>SMPD1</italic> variants p.V36A, p.P325A, p.A487V and p.G508R were generated by site-directed mutagenesis. The variant cDNAs and the empty FLAG-N2 vector (mock) were transiently transfected into MDCK cells, and acid sphingomyelinase activity was determined from cell lysates (L-ASM activity; <bold>upper</bold> panel) and supernatants (S-ASM activity; <bold>lower</bold> panel). Representative results of a typical experiment with three replicates are given as fold increase over the mock-transfected control. Error bars indicate the standard deviation. With the exception of p.P325A, all mutants increased acid sphingomyelinase activity by &#x0003e;fivefold, similarly to <italic>SMPD1</italic> wild-type. Methods are described in detail in [<xref rid="B5-ijms-16-13649" ref-type="bibr">5</xref>].</p></caption><graphic xlink:href="ijms-16-13649-g001"/></fig></sec><sec><title>2. Conclusions</title><p>Our results strongly support the notion that p.V36A, p.A487V and p.G508R are frequent polymorphisms in <italic>SMPD1</italic>. These polymorphisms might increase the susceptibility for common diseases such as allergy [<xref rid="B6-ijms-16-13649" ref-type="bibr">6</xref>], but they do not constitute loss-of-function mutations that are responsible for the occurrence of NPD. Since the alleged loss-of function mutations in 12 out of 15 NPD patients reported by Manshadi <italic>et al.</italic> [<xref rid="B9-ijms-16-13649" ref-type="bibr">9</xref>] are common polymorphisms, a critical molecular, biochemical and clinical evaluation of the mentioned patients is recommended.</p></sec></body><back><notes><title>Author Contributions</title><p>Cosima Rhein, Johannes Kornhuber and Martin Reichel conceived and designed the experiments; Cosima Rhein, Christiane M&#x000fc;hle and Martin Reichel performed the experiments; Cosima Rhein and Martin Reichel analyzed the data; Martin Reichel wrote the paper.</p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-16-13649"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kornhuber</surname><given-names>J.</given-names></name><name><surname>Medlin</surname><given-names>A.</given-names></name><name><surname>Bleich</surname><given-names>S.</given-names></name><name><surname>Jendrossek</surname><given-names>V.</given-names></name><name><surname>Henkel</surname><given-names>A.W.</given-names></name><name><surname>Wiltfang</surname><given-names>J.</given-names></name><name><surname>Gulbins</surname><given-names>E.</given-names></name></person-group>
<article-title>High activity of acid sphingomyelinase in major depression</article-title>
<source>J. Neural Transm.</source>
<year>2005</year>
<volume>112</volume>
<fpage>1583</fpage>
<lpage>1590</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-005-0374-5</pub-id>
<pub-id pub-id-type="pmid">16245071</pub-id></element-citation></ref><ref id="B2-ijms-16-13649"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simonaro</surname><given-names>C.M.</given-names></name><name><surname>Desnick</surname><given-names>R.J.</given-names></name><name><surname>McGovern</surname><given-names>M.M.</given-names></name><name><surname>Wasserstein</surname><given-names>M.P.</given-names></name><name><surname>Schuchman</surname><given-names>E.H.</given-names></name></person-group>
<article-title>The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations</article-title>
<source>Am. J. Hum. Genet.</source>
<year>2002</year>
<volume>71</volume>
<fpage>1413</fpage>
<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1086/345074</pub-id>
<pub-id pub-id-type="pmid">12369017</pub-id></element-citation></ref><ref id="B3-ijms-16-13649"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuchman</surname><given-names>E.H.</given-names></name><name><surname>Levran</surname><given-names>O.</given-names></name><name><surname>Suchi</surname><given-names>M.</given-names></name><name><surname>Desnick</surname><given-names>R.J.</given-names></name></person-group>
<article-title>An MspI polymorphism in the human acid sphingomyelinase gene (<italic>SMPD1</italic>)</article-title>
<source>Nucleic Acids Res.</source>
<year>1991</year>
<volume>19</volume>
<fpage>3160</fpage>
<pub-id pub-id-type="doi">10.1093/nar/19.11.3160</pub-id>
<pub-id pub-id-type="pmid">1711683</pub-id></element-citation></ref><ref id="B4-ijms-16-13649"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wan</surname><given-names>Q.</given-names></name><name><surname>Schuchman</surname><given-names>E.H.</given-names></name></person-group>
<article-title>A novel polymorphism in the human acid sphingomyelinase gene due to size variation of the signal peptide region</article-title>
<source>Biochim. Biophys. Acta</source>
<year>1995</year>
<volume>1270</volume>
<fpage>207</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/0925-4439(95)00050-E</pub-id>
<pub-id pub-id-type="pmid">7727545</pub-id></element-citation></ref><ref id="B5-ijms-16-13649"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rhein</surname><given-names>C.</given-names></name><name><surname>Naumann</surname><given-names>J.</given-names></name><name><surname>M&#x000fc;hle</surname><given-names>C.</given-names></name><name><surname>Zill</surname><given-names>P.</given-names></name><name><surname>Adli</surname><given-names>M.</given-names></name><name><surname>Hegerl</surname><given-names>U.</given-names></name><name><surname>Hiemke</surname><given-names>C.</given-names></name><name><surname>Mergl</surname><given-names>R.</given-names></name><name><surname>Moller</surname><given-names>H.J.</given-names></name><name><surname>Reichel</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>The acid sphingomyelinase sequence variant p.A487V is not associated with decreased levels of enzymatic activity</article-title>
<source>JIMD Rep.</source>
<year>2013</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">23430512</pub-id></element-citation></ref><ref id="B6-ijms-16-13649"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reichel</surname><given-names>M.</given-names></name><name><surname>Richter-Schmidinger</surname><given-names>T.</given-names></name><name><surname>M&#x000fc;hle</surname><given-names>C.</given-names></name><name><surname>Rhein</surname><given-names>C.</given-names></name><name><surname>Alexopoulos</surname><given-names>P.</given-names></name><name><surname>Schwab</surname><given-names>S.G.</given-names></name><name><surname>Gulbins</surname><given-names>E.</given-names></name><name><surname>Kornhuber</surname><given-names>J.</given-names></name></person-group>
<article-title>The common acid sphingomyelinase polymorphism p.G508R is associated with self-reported allergy</article-title>
<source>Cell. Physiol. Biochem.</source>
<year>2014</year>
<volume>34</volume>
<fpage>82</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1159/000362986</pub-id>
<pub-id pub-id-type="pmid">24977483</pub-id></element-citation></ref><ref id="B7-ijms-16-13649"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Dagan</surname><given-names>A.</given-names></name><name><surname>Gatt</surname><given-names>S.</given-names></name><name><surname>Schuchman</surname><given-names>E.H.</given-names></name></person-group>
<article-title>A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease</article-title>
<source>Anal. Biochem.</source>
<year>2003</year>
<volume>314</volume>
<fpage>116</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/S0003-2697(02)00629-2</pub-id>
<pub-id pub-id-type="pmid">12633609</pub-id></element-citation></ref><ref id="B8-ijms-16-13649"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rhein</surname><given-names>C.</given-names></name><name><surname>Reichel</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;hle</surname><given-names>C.</given-names></name><name><surname>Rotter</surname><given-names>A.</given-names></name><name><surname>Schwab</surname><given-names>S.G.</given-names></name><name><surname>Kornhuber</surname><given-names>J.</given-names></name></person-group>
<article-title>Secretion of acid sphingomyelinase is affected by its polymorphic signal peptide</article-title>
<source>Cell. Physiol. Biochem.</source>
<year>2014</year>
<volume>34</volume>
<fpage>1385</fpage>
<lpage>1401</lpage>
<pub-id pub-id-type="doi">10.1159/000366345</pub-id>
<pub-id pub-id-type="pmid">25301364</pub-id></element-citation></ref><ref id="B9-ijms-16-13649"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manshadi</surname><given-names>M.D.</given-names></name><name><surname>Kamalidehghan</surname><given-names>B.</given-names></name><name><surname>Keshavarzi</surname><given-names>F.</given-names></name><name><surname>Aryani</surname><given-names>O.</given-names></name><name><surname>Dadgar</surname><given-names>S.</given-names></name><name><surname>Arastehkani</surname><given-names>A.</given-names></name><name><surname>Tondar</surname><given-names>M.</given-names></name><name><surname>Ahmadipour</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>G.Y.</given-names></name><name><surname>Houshmand</surname><given-names>M.</given-names></name></person-group>
<article-title>Four novel p.N385K, p.V36A, c.1033&#x02013;1034insT and c.1417&#x02013;1418delCT mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene in patients with types A and B Niemann-Pick disease (NPD)</article-title>
<source>Int. J. Mol. Sci.</source>
<year>2015</year>
<volume>16</volume>
<fpage>6668</fpage>
<lpage>6676</lpage>
<pub-id pub-id-type="doi">10.3390/ijms16046668</pub-id>
<pub-id pub-id-type="pmid">25811928</pub-id></element-citation></ref></ref-list></back></article>